focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
https://www.gov.uk/government/news/trial-of-rapid-coronavirus-test-launched-in-hampshire
It s a LAMP test
https://twitter.com/carolecadwalla/status/1303953046230241281?s=21
Doesn’t seem like there’s a plan for a meaningful company - too many shady deals too many lth given up the ghost and bailed. Hope it comes good but not much good news coming out of any oil co at the moment.
Boris probably has a clear blue in his hand however
Guys I am a holder here but what are people’s thoughts on the test being anti-body? I missed the press release and have read the bbc, which is usually wrong, and it sounds more antigen? Am I missing. Something?
Seems plasma harvesting will be the main gig before testing for vaccine established antibodies
Interesting pieces of news out there today. PCR tests potentially picking up dead virus due to being overly sensitive and the Russian vaccine generating immune response- if you believe that.
Yes - requires a machine alongside.
Odx could end up a company of national interest or like Rolls Royce
Makes sense as an rns would be required also. If you want a piece of Mologic then it has to be through ODX
Merchant - can’t argue with maths. I think this growth would be off the scale to manage but I think you are on the right curve. For a gross sales to value position it will be interesting to see what ncyt do when their numbers are published as that will be the base line chart for odx imho. There was a similar shape with that share eventually popping to over £5 ps. Sales and agreements will be the cracking of the atom event here. Could be all too soon
Also both cos are private and cant release market information on behalf of ODX. Involvement etc should be communicated by odx rns
Everyone has teeth ??????
Didn’t think a machine came with our abc test? Saw news yesterday Scotland was buying machines from a Stirling based company for antigen
Odx took a downward swing, in my opinion, when there was some dubiety around anti-bodies. Now they are a hot topic again and we are on the cusp there is little action on the price. Maybe some impatience but i will hold for the longer term. Grrr
Odx and the rtc just seem to have the right test at the right time. There is a lot to be said for that.
But the Roche and abbot tests were shown to be inaccurate no matter what they really us they are trying to measure. Interested in where t4 calls goes also
Remember ncyt were pretty much the first to a highly accuracy antigen test ce marked in feb, I think. Yet the company sold millions overseas before the uk government woke up
Tricky - I haven’t gone through the bones just watched the Colin king interview which was pretty detailed. Thanks for adding capacity information I want to look at the relative payback on the capacity injection. My main focus is covid impact at the moment but some of the tests that were highlighted could be huge for the company also. Number 1 health insurance claims in the uk are gastro related. I am thinking 400 in October if the sales info rolls in I spoke to a gent this week who runs a lab who mentioned the verdict is still out on antibody testing which might be the only reason we are sitting where we are. A large government order and it could blow the doors off from a acceptance basis. However as is known odx has a capability in many corners including antigen, t4, allergy etc. Hoping for a strong run through to October at least